1. Home
  2. USCB vs EOLS Comparison

USCB vs EOLS Comparison

Compare USCB & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USCB Financial Holdings Inc.

USCB

USCB Financial Holdings Inc.

HOLD

Current Price

$18.56

Market Cap

335.0M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.17

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USCB
EOLS
Founded
2002
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.0M
284.3M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
USCB
EOLS
Price
$18.56
$6.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$23.00
$15.50
AVG Volume (30 Days)
74.9K
886.6K
Earning Date
04-23-2026
05-04-2026
Dividend Yield
2.72%
N/A
EPS Growth
7.26
1.23
EPS
0.51
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
$26.46
$13.27
Revenue Next Year
$9.67
$17.62
P/E Ratio
$36.33
N/A
Revenue Growth
N/A
11.61
52 Week Low
$15.57
$3.86
52 Week High
$20.79
$10.62

Technical Indicators

Market Signals
Indicator
USCB
EOLS
Relative Strength Index (RSI) 50.53 55.97
Support Level $17.80 $5.94
Resistance Level $18.82 $6.40
Average True Range (ATR) 0.49 0.36
MACD 0.05 -0.05
Stochastic Oscillator 60.96 52.85

Price Performance

Historical Comparison
USCB
EOLS

About USCB USCB Financial Holdings Inc.

USCB Financial Holdings Inc is a bank holding company. Through its banking subsidiary, it offers relationship-based banking products, services, and solutions to a diverse set of clients in the local markets it operates in and international clients with U.S. banking needs. The Group's products and services offerings mainly include traditional deposit products, including commercial and consumer checking accounts, money market deposit accounts, savings accounts, etc.; e-banking services; title insurance policies for real estate transactions; and a variety of lending products such as small business loans, commercial real estate loans, business credit cards, etc.; and others. Geographically, its primary banking market is South Florida.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: